| |
PRODUCTS, SERVICES
Pharmaceuticals
Inhalers, Research Respiratory Drug Development Clinical Trials
Pharmaceutical Inhaler Clinical Trials
Respiratory drug development research, cancer treatment, diabetes oral drug delivery
|
 |
Showing 1-7
of 7
 = product catalog / search specs
|
|
|
Alkermes Inc - Injectable Extended Release Pharmaceuticals, Pulmonary Drug Delivery Systems, Stock Symbol ALKS
Cambridge, MA USA 617 494 0171 |
|
Alkermes Inc $240 Million sales 700 employees, schizophrenia extended release formulation pharmaceuticals, extended release alcohol dependence treatment injectable suspension, insulin diabetes extended release clinical trials
|
Aradigm Corp - Pulmonary Drug Delivery Development, CF Cystic Fibrosis, Bronchiectasis, Stock Symbol ARDM
Hayward, CA USA 510 265 9000 |
|
|
Archimedes Pharma Ltd - Oral Sustained Release Morphine, Neuroleptic Nausea Treatment, Private Ownership
Green Park, Reading UK 44 118 931 5050 |
|
Archimedes (previously West Pharmaceutical drug delivery) proprietary technologies nasal drug delivery
|
Generex Biotechnology - Metered Dose Oral Spray Inhaler Clinical Trials, Diabetes, Cancer, Pain , Stock GNBT
Toronto, ON Canada 416 364 2551 |
|
|
MannKind Pharmaceutical Corp - Dry Powder Insulin Inhaler Development, Diabetes Cancer Treatment, Stock Symbol MNKD
Valencia, CA USA 661 775 5300 |
|
|
Nektar Therapeutics - PEG Polyethylene Glycol Oral Drug Delivery, Inhalation Powder Drug Development, Stock Symbol NKTR
San Carlos, CA USA 650 631 3100 |
|
Nektar Therapeutics $45 Million sales
|
Oriel Therapeutics Inc - Asthma Treatment Dry Powder Inhaler Medical Device Development, Private Ownership
Durham, NC USA 919 313 1290 |
|
|
| Showing 1-7
of 7
|
|
